{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Corona",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "64312",
      "recalling_firm": "Watson Laboratories Inc",
      "address_1": "311 Bonnie Cir",
      "address_2": "N/A",
      "postal_code": "92880-2882",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "recall_number": "D-204-2013",
      "product_description": "Meprobamate; Tablets USP, 400 mg, 100 tablets; Rx only;  Manufactured By: Watson Laboratories, Inc., Corona, CA 92800 USA; 173266; . Distributed by: Watson Pharma, Inc., NDC 0591-5238-01",
      "product_quantity": "20,587 bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: Watson Laboratories Inc. is recalling meprobamate  because an out of specification result for an impurity diphenyl sulfone .",
      "recall_initiation_date": "20130208",
      "center_classification_date": "20130319",
      "termination_date": "20140131",
      "report_date": "20130327",
      "code_info": "387879A, Exp. 02/13; 429105A, Exp. 06/13; 474488A, Exp. 11/13; 491672A, Exp. 01/14; 529095A, Exp. 04/14"
    }
  ]
}